TCL Archive The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation May 14, 2010
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive In Brief: Rhoads, Schmidt Bow Out – Amos, Krim Possible Replacements; Sibal acting Virology Director January 27, 1978
